Fred Middleton is the Founder and Managing Director of Sanderling Ventures. See sector focus and contact routes.
Fred Middleton is the Founder and Managing Director of Sanderling Ventures, a San Mateo-based firm that invests exclusively in early-stage biomedical companies across biopharmaceuticals, medical devices, and healthcare IT. His portfolio includes notable companies such as ViaCyte, Glycomine, Axikin Pharmaceuticals, and CalciMedica, where he serves as an independent director. Middleton’s distinctive thesis combines deep biotechnology operating experience (including as Genentech’s first CFO) with institutional venture capital to target drug discovery and delivery platforms in the biomedical sector.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in San Mateo.
Investors like Fred Middleton · Full investor directory · Investor access · Company funding database